Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Lazard commenced a marketing process for certain markets, expanded over time to substantially all of the Company's markets, discussing a potential purchase of some or all assets with over 50 potential acquirers
Moreover, pharmaceutical firms are actively profiting from this trend by executing clinical trials and striving for regulatory validation for weight management indications, further broadening the markets prospects
See our complete cost guide for all options
KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)
US$ 21.25
US$ 20.44
US$ 22.68
US$ 29.35
US$ 20.94
US$ 28.84
US$ 21.23
US$ 22.76
